Hayat Pharmaceutical Industries Co. PLC reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was JOD 4.34 million compared to JOD 5 million a year ago. Net income was JOD 1.06 million compared to JOD 0.895515 million a year ago. Basic earnings per share from continuing operations was JOD 0.11 compared to JOD 0.09 a year ago. For the nine months, sales was JOD 13.63 million compared to JOD 12.66 million a year ago. Net income was JOD 3.62 million compared to JOD 2.54 million a year ago. Basic earnings per share from continuing operations was JOD 0.38 compared to JOD 0.27 a year ago.